Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 23% ± 6% | |
capillary endothelial cell | 6 studies | 27% ± 5% | |
epithelial cell | 5 studies | 32% ± 10% | |
ciliated cell | 3 studies | 26% ± 4% | |
goblet cell | 3 studies | 28% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2831.86 | 180 / 180 | 100% | 62.86 | 430 / 430 |
uterus | 100% | 2906.82 | 170 / 170 | 100% | 46.97 | 458 / 459 |
pancreas | 100% | 2114.82 | 328 / 328 | 99% | 39.58 | 177 / 178 |
prostate | 100% | 5048.15 | 245 / 245 | 99% | 77.58 | 499 / 502 |
esophagus | 100% | 2794.54 | 1444 / 1445 | 99% | 43.88 | 182 / 183 |
thymus | 100% | 3856.33 | 653 / 653 | 99% | 32.75 | 599 / 605 |
intestine | 100% | 2924.71 | 966 / 966 | 99% | 43.06 | 521 / 527 |
kidney | 100% | 4029.54 | 89 / 89 | 99% | 28.91 | 890 / 901 |
skin | 100% | 3589.18 | 1809 / 1809 | 99% | 43.28 | 466 / 472 |
stomach | 100% | 2363.22 | 359 / 359 | 99% | 41.65 | 282 / 286 |
breast | 100% | 2800.56 | 457 / 459 | 99% | 52.55 | 1106 / 1118 |
lung | 100% | 4729.69 | 578 / 578 | 98% | 39.43 | 1131 / 1155 |
adrenal gland | 100% | 2312.24 | 258 / 258 | 98% | 25.80 | 225 / 230 |
bladder | 100% | 2462.05 | 21 / 21 | 98% | 46.99 | 492 / 504 |
brain | 99% | 1490.08 | 2626 / 2642 | 97% | 18.41 | 685 / 705 |
liver | 100% | 1695.54 | 226 / 226 | 88% | 19.70 | 357 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 51.51 | 80 / 80 |
spleen | 100% | 1663.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.55 | 1 / 1 |
adipose | 99% | 1365.94 | 1194 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1190.36 | 1320 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 1146.92 | 802 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 903.87 | 728 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 4.93 | 13 / 29 |
peripheral blood | 29% | 282.54 | 269 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000352 | Biological process | negative regulation of endothelial cell apoptotic process |
GO_0001558 | Biological process | regulation of cell growth |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0007165 | Biological process | signal transduction |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0060996 | Biological process | dendritic spine development |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0016477 | Biological process | cell migration |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0098641 | Molecular function | cadherin binding involved in cell-cell adhesion |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PAK4 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) cDNA FLJ61413, highly similar to Serine/threonine-protein kinase PAK 4 (p21(CDKN1A)-activated kinase 4, isoform CRA_e) Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) P21 (RAC1) activated kinase 4 |
Synonyms | KIAA1142 hCG_20282 |
Description | FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. . |
Accessions | ENST00000593690.5 [O96013-1] ENST00000599386.5 [O96013-3] M0R3G6 O96013 ENST00000599657.5 ENST00000360442.8 [O96013-1] M0R0L9 M0R2X4 ENST00000593480.5 ENST00000599470.5 [O96013-3] B4DUG0 M0R1R1 ENST00000321944.8 [O96013-4] ENST00000358301.7 [O96013-1] ENST00000597715.1 ENST00000602004.1 |